Correspondence 0001104659-23-121152 from Structure Therapeutics Inc. (GPCR) (CIK 0001888886) (GPCR)
Structure Therapeutics Inc. (GPCR) (CIK 0001888886)
Date: Nov. 27, 2023 · CIK: 0001888886 · Accession: 0001104659-23-121152
AI Filing Summary & Sentiment
File numbers found in text: 333-275651
Letter
Structure Therapeutics Inc.
601 Gateway Blvd., Suite 900
South San Francisco, CA 94080
November 27, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Joshua Gorsky
Re: Structure Therapeutics Inc.
Registration Statement on Form S-1
Filed November 17, 2023
File No. 333-275651
Acceleration Request
Requested Date: November 29, 2023
Requested Time: 4:00 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Structure Therapeutics Inc. hereby requests that the U.S. Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) and declare the Registration Statement effective as of 4:00 p.m. Eastern Time, on November 29, 2023, or as soon thereafter as practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Patrick Loofbourrow of Cooley LLP at (619) 840-4824, or in his absence, Carlos Ramirez of Cooley LLP at (858) 550-6157.
Sincerely,
Structure Therapeutics Inc.
Show Raw Text
CORRESP
1
filename1.htm
Structure Therapeutics Inc.
601 Gateway Blvd., Suite 900
South San Francisco, CA 94080
November 27, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Joshua Gorsky
Re:
Structure Therapeutics Inc.
Registration Statement on Form S-1
Filed November 17, 2023
File No. 333-275651
Acceleration Request
Requested Date: November 29, 2023
Requested Time: 4:00 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities
Act of 1933, as amended, Structure Therapeutics Inc. hereby requests that the U.S. Securities and Exchange Commission accelerate the effective
date of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) and declare
the Registration Statement effective as of 4:00 p.m. Eastern Time, on November 29, 2023, or as soon thereafter as practicable.
Once the Registration Statement has been declared
effective, please orally confirm that event with Patrick Loofbourrow of Cooley LLP at (619) 840-4824, or in his absence, Carlos Ramirez
of Cooley LLP at (858) 550-6157.
Sincerely,
Structure Therapeutics Inc.
By:
/s/ Raymond Stevens
Raymond Stevens, Ph.D.
Chief Executive Officer